52 Week Range
As of on the Tokyo Stock Exchange ∙ Minimum 15 minute delay
3M AVG Volume
52 Week High
52 Week Low
Shares Out (MIL)
Market Cap (MIL)
Dividend (Yield %)
Terumo Signs Agreement To Acquire All Assets Of Health Outcomes Sciences
Balt Contests Allegations By MicroVention
Microvention- Filed Second Lawsuit Against Balt Usa, Llc And Four Former Employees For Trade Secret Misappropriation
TERUMO CORPORATION is a manufacturer of medical supplies. The Company operates in three segments. The Cardiac and Vascular Company segment is engaged in the manufacture of catheter system and cardiopulmonary system products, the import of the cardiopulmonary systems and artificial blood vessels, as well as the sale of products mainly to hospitals and clinics nationwide through agents. The Hospital Company segment is engaged in the manufacture, purchase and sale of hospital medical equipment, pharmaceuticals, peritoneal dialysis and diabetes related products, and the rental of hospital medical equipment and home medical products. The segment is also engaged in the manufacture and sale of healthcare related products. The Blood System Company segment is engaged in the manufacture and sale of blood transfusion-related products.
Medical Equipment & Supplies
Chairman of the Board, Representative Director
President, Chief Executive Officer, Representative Director
Executive Officer, Chief Accounting & Financial Officer, Director of Accounting
Managing Executive Officer, Chief Human Resource Officer, Director
Chief Technology Officer, Senior Executive Officer, Manager of Business Planning Office
Price To Earnings (TTM)
Price To Sales (TTM)
Price To Book (MRQ)
Price To Cash Flow (TTM)
Total Debt To Equity (MRQ)
LT Debt To Equity (MRQ)
Return on Investment (TTM)
Return on Equity (TTM)
Japanese shares fell on Friday, weighed down by tech stocks and caution ahead of U.S. inflation data, but posted their first weekly gain in three on easing worries over the Omicron coronavirus variant's impact on the pace of economic recovery.
Japanese shares fell on Friday, weighed down by tech stocks and caution ahead of U.S. inflation data, but benchmark indexes were set for their first weekly gain in three as fears around the Omicron coronavirus variant eased.
Japanese shares ended lower on Friday, weighed down by uncertainties about outlook of domestic firms, while gains in technology stocks tracking an overnight Nasdaq rally limited losses.
Japanese shares fell on Friday, weighed down by uncertainties about domestic corporate outlook, while gains in chip-related shares tracking their U.S. peers limited losses.
Japanese shares ended higher on Thursday, led by heavyweight tech stocks that tracked gains on the Nasdaq, with chip equipment maker Tokyo Electron providing the biggest boost for the Nikkei.
Japan's Nikkei share average rose on Thursday, tracking the Nasdaq overnight, with gains led by chip equipment maker Tokyo Electron and other heavyweight technology stocks.
Japanese shares closed lower on Tuesday after a three-session rally, tracking a weaker finish on Wall Street and as big tech stocks sold off amid fears over higher U.S. interest rates.
Japanese shares fell on Tuesday after a three-session rally, tracking a weaker finish on Wall Street and as fears over higher U.S. interest rates drove a sell-off in big technology stocks.
Japan's Nikkei index slid on Friday, in line with Wall Street's declines overnight, on caution around prospects for an earlier-than-expected tapering of Federal Reserve stimulus.
Japan's Nikkei index slid on Friday, in line with Wall Street's declines overnight, on caution around prospects for an earlier tapering of Federal Reserve stimulus.
Japanese shares closed lower on Thursday, weighed down by worries that a resurgence of COVID-19 infections would lead to an extension of restrictions and slow the economic recovery.
Japanese shares reversed course to trade lower on Thursday on concerns that a resurgence of COVID-19 infections would lead to an extension of restrictions, slowing economic recovery.
Japanese stocks closed lower on Friday, with the Topix index dragged lower by financial stocks and Toyota Motor's retreat from a record high.
Japan's benchmark Nikkei inched up on Friday as technology stocks tracked a strong finish on the tech-heavy Nasdaq index, while the broader Topix index fell after Toyota Motor retreated from its record high.
* Seven&i gains after ValueAct stake; Sumitomo Mitsui Trust up
Japanese shares sank on Thursday, with the Nikkei average hitting a four-month low, as SoftBank Group and highly valued stocks were pummelled by U.S. inflation scare.
Japanese shares closed higher on Thursday as investors picked up beaten-down cyclical stocks, although gains were capped by investors cutting their positions in some index heavyweights.
Japanese shares inched higher on Thursday as investors picked up beaten-down cyclical stocks while cutting their positions in some index heavyweights.
Japan's Terumo Corp said on Tuesday it has developed a new syringe that can get seven doses out of each vial of COVID-19 vaccine made by Pfizer Inc, at least one more than accessible with existing syringes.
Japan will kick off its COVID-19 vaccination programme on Wednesday amid concerns that a shortage of special syringes could lead to the waste of millions of doses of Pfizer vaccine as the country grapples with its third and most serious wave of infections.
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.